T2 Biosystems (NASDAQ:TTOO – Get Free Report) is scheduled to announce its earnings results after the market closes on Thursday, November 14th. Investors interested in registering for the company’s conference call can do so using this link.
T2 Biosystems Price Performance
T2 Biosystems stock opened at $0.52 on Wednesday. T2 Biosystems has a 1-year low of $0.51 and a 1-year high of $8.38. The company’s 50-day moving average is $1.71 and its 200 day moving average is $3.57.
Analysts Set New Price Targets
TTOO has been the topic of several recent analyst reports. StockNews.com upgraded T2 Biosystems to a “sell” rating in a report on Tuesday, July 30th. Canaccord Genuity Group lifted their target price on T2 Biosystems from $3.00 to $5.00 and gave the stock a “hold” rating in a research report on Tuesday, July 30th.
T2 Biosystems Company Profile
T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
Further Reading
- Five stocks we like better than T2 Biosystems
- Golden Cross Stocks: Pattern, Examples and Charts
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- What is MarketRank™? How to Use it
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- How to Read Stock Charts for Beginners
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
